Literature DB >> 33523517

Predictors for readmission due to cellulitis among Japanese patients.

Yuta Norimatsu1,2, Yuki Ohno1.   

Abstract

Cellulitis is an infection of the soft tissues of the skin. Some patients are hospitalized multiple times; lymphedema, chronic venous insufficiency, peripheral circulatory disturbance, and deep vein thrombosis are said to be risk factors for multiple admissions. Conversely, in Japan, elderly women and undernourished elderly have been reported to be at risk of multiple hospitalizations, suggesting a different patient background from that reported overseas. We investigated the characteristics of readmission cases for patients hospitalized for cellulitis in Japan. We retrospectively examined cases of cellulitis and erysipelas admitted between April 1, 2005 and March 31, 2018. Patients with cellulitis or erysipelas at multiple sites and those with osteomyelitis, pressure ulcer infection, and necrotizing fasciitis were excluded. In terms of recurrence, only hospitalizations for recurrence at the same site were considered. Patients with multiple hospitalizations had significantly lower blood albumin levels than those hospitalized only once. Furthermore, the rates of lymphedema, hypertension, and hyperlipidemia were significantly higher in patients hospitalized multiple times. Other laboratory and clinical factors were not statistically significant. Therefore, hypoalbuminemia with or without liver dysfunction, lymphedema, hypertension, and hyperlipidemia were suggested as risk factors for cellulitis recurrence. However, chronic venous insufficiency, peripheral circulatory disturbance, and deep vein thrombosis did not seem to be risk factors in Japanese cases. Japanese cases had a low body mass index (approximately 25 kg/m2 ), suggesting that the patient background may be different from that in existing reports. This suggests that the risk factors in Japanese cases may be different from those reported in other countries.
© 2021 The Authors. The Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association.

Entities:  

Keywords:  cellulitis; hyperlipidemia; hypertension; hypoalbuminemia; lymphedema

Year:  2021        PMID: 33523517     DOI: 10.1111/1346-8138.15771

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  7 in total

Review 1.  Cellulitis: A Review of Current Practice Guidelines and Differentiation from Pseudocellulitis.

Authors:  Michelle A Boettler; Benjamin H Kaffenberger; Catherine G Chung
Journal:  Am J Clin Dermatol       Date:  2021-12-13       Impact factor: 7.403

2.  Malnutrition, hypertension, and hyperlipidemia as risk factors for recurrent cellulitis.

Authors:  Yurie Norimatsu; Yuta Norimatsu
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-05-03

Review 3.  Accuracy of CREST Guideline in Management of Cellulitis in Emergency Department; a Systematic Review and Meta-analysis.

Authors:  Hossein Akhavan; Seyed Reza Habibzadeh; Fatemeh Maleki; Mahdi Foroughian; Sayyed Reza Ahmadi; Reza Akhavan; Bita Abbasi; Behzad Shahi; Navid Kalani; Naser Hatami; Amir Mangouri; Sheida Jamalnia
Journal:  Arch Acad Emerg Med       Date:  2021-11-03

4.  Prophylactic antimicrobials may not be needed to prevent surgical site infection after skin biopsy: a retrospective study.

Authors:  Yuko Akiyama; Yuta Norimatsu; Yuki Ohno
Journal:  Antimicrob Resist Infect Control       Date:  2022-02-16       Impact factor: 4.887

Review 5.  Recurrent Cellulitis: Who is at Risk and How Effective is Antibiotic Prophylaxis?

Authors:  Bin S Ong; Ravindra Dotel; Vincent Jiu Jong Ngian
Journal:  Int J Gen Med       Date:  2022-08-10

6.  Reply.

Authors:  Shuhei Yoshida; Isao Koshima; Hirofumi Imai; Ayano Sasaki; Shogo Nagamatsu; Kazunori Yokota
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-05-03

7.  Scrotal Abscess in a Japanese Patient Caused by Prevotella bivia and Streptococcus agalactiae, Successfully Treated with Cefazolin and Amoxicillin: A Case Report.

Authors:  Haruka Watanabe; Yuta Norimatsu; Yuki Ohno
Journal:  Int Med Case Rep J       Date:  2021-07-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.